The role of SLC9A3 in Taiwanese patients with congenital bilateral absence of vas deferens (CBAVD)

Congenital bilateral absence of vas deferens (CBAVD) is a special entity in obstructive azoospermia. Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene are involved in Taiwanese CBAVD but most heterozygous 5T variant. The solute carrier family 9 isoform 3 (SLC9A3) is th...

Full description

Bibliographic Details
Main Authors: Han-Sun Chiang, Ya-Yun Wang, Ying-Hung Lin, Yi-No Wu
Format: Article
Language:English
Published: Elsevier 2019-12-01
Series:Journal of the Formosan Medical Association
Online Access:http://www.sciencedirect.com/science/article/pii/S0929664618305291
id doaj-d7d46520016f4357a7bd57775b64ae4e
record_format Article
spelling doaj-d7d46520016f4357a7bd57775b64ae4e2020-11-25T02:22:52ZengElsevierJournal of the Formosan Medical Association0929-66462019-12-011181215761583The role of SLC9A3 in Taiwanese patients with congenital bilateral absence of vas deferens (CBAVD)Han-Sun Chiang0Ya-Yun Wang1Ying-Hung Lin2Yi-No Wu3Graduate Institute of Biomedical and Pharmaceutical Science, Fu Jen Catholic University, New Taipei City, Taiwan; Department of Urology, Fu Jen Catholic University Hospital, New Taipei City, TaiwanGraduate Institute of Biomedical and Pharmaceutical Science, Fu Jen Catholic University, New Taipei City, TaiwanGraduate Institute of Biomedical and Pharmaceutical Science, Fu Jen Catholic University, New Taipei City, TaiwanSchool of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan; Corresponding author. School of Medicine, Fu Jen Catholic University, 510 Chung-Cheng Road, Hsinchuang, New Taipei City 24205, Taiwan, ROC. Fax: +886 2 29017391.Congenital bilateral absence of vas deferens (CBAVD) is a special entity in obstructive azoospermia. Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene are involved in Taiwanese CBAVD but most heterozygous 5T variant. The solute carrier family 9 isoform 3 (SLC9A3) is the Na+/H+ exchanger, which interacts with CFTR and regulates the Ca2+ homeostasis. Loss of SLC9A3 decreases CFTR protein and causes obstructive azoospermia in mice. It also causes mal-reabsorption by the efferent tubules, which leads to the obstructive phenomenon and eventually results in testicular atrophy. In 6-month old SLC9A3 deficiency mice, the atrophy of their vas deferens and seminal vesicles become more prominent. Decreases of CFTR expression in the reproductive organ in the SLC9A3 deficient (−/−) mice prove the interaction between CFTR and SLC9A3 in the reproductive tract. Most of Taiwanese CBAVD have at least one variant of SLC9A3 deletion and CFTR IVS8-5T, which co-contribute to Taiwanese CBAVD. The report indicates SLC9A3 deficiency can reverse the pathological changes in the gastrointestinal tract of CF mice. Further research can explore the definite mechanism of SLC9A3 and its role interacting with CFTR in different organ systems, which can contribute to novel treatment for the patients with cystic fibrosis and CBAVD. Keywords: Congenital bilateral absence of vas deferens, Cystic fibrosis transmembrane conductance regulator, Solute carrier family 9 isoform 3http://www.sciencedirect.com/science/article/pii/S0929664618305291
collection DOAJ
language English
format Article
sources DOAJ
author Han-Sun Chiang
Ya-Yun Wang
Ying-Hung Lin
Yi-No Wu
spellingShingle Han-Sun Chiang
Ya-Yun Wang
Ying-Hung Lin
Yi-No Wu
The role of SLC9A3 in Taiwanese patients with congenital bilateral absence of vas deferens (CBAVD)
Journal of the Formosan Medical Association
author_facet Han-Sun Chiang
Ya-Yun Wang
Ying-Hung Lin
Yi-No Wu
author_sort Han-Sun Chiang
title The role of SLC9A3 in Taiwanese patients with congenital bilateral absence of vas deferens (CBAVD)
title_short The role of SLC9A3 in Taiwanese patients with congenital bilateral absence of vas deferens (CBAVD)
title_full The role of SLC9A3 in Taiwanese patients with congenital bilateral absence of vas deferens (CBAVD)
title_fullStr The role of SLC9A3 in Taiwanese patients with congenital bilateral absence of vas deferens (CBAVD)
title_full_unstemmed The role of SLC9A3 in Taiwanese patients with congenital bilateral absence of vas deferens (CBAVD)
title_sort role of slc9a3 in taiwanese patients with congenital bilateral absence of vas deferens (cbavd)
publisher Elsevier
series Journal of the Formosan Medical Association
issn 0929-6646
publishDate 2019-12-01
description Congenital bilateral absence of vas deferens (CBAVD) is a special entity in obstructive azoospermia. Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene are involved in Taiwanese CBAVD but most heterozygous 5T variant. The solute carrier family 9 isoform 3 (SLC9A3) is the Na+/H+ exchanger, which interacts with CFTR and regulates the Ca2+ homeostasis. Loss of SLC9A3 decreases CFTR protein and causes obstructive azoospermia in mice. It also causes mal-reabsorption by the efferent tubules, which leads to the obstructive phenomenon and eventually results in testicular atrophy. In 6-month old SLC9A3 deficiency mice, the atrophy of their vas deferens and seminal vesicles become more prominent. Decreases of CFTR expression in the reproductive organ in the SLC9A3 deficient (−/−) mice prove the interaction between CFTR and SLC9A3 in the reproductive tract. Most of Taiwanese CBAVD have at least one variant of SLC9A3 deletion and CFTR IVS8-5T, which co-contribute to Taiwanese CBAVD. The report indicates SLC9A3 deficiency can reverse the pathological changes in the gastrointestinal tract of CF mice. Further research can explore the definite mechanism of SLC9A3 and its role interacting with CFTR in different organ systems, which can contribute to novel treatment for the patients with cystic fibrosis and CBAVD. Keywords: Congenital bilateral absence of vas deferens, Cystic fibrosis transmembrane conductance regulator, Solute carrier family 9 isoform 3
url http://www.sciencedirect.com/science/article/pii/S0929664618305291
work_keys_str_mv AT hansunchiang theroleofslc9a3intaiwanesepatientswithcongenitalbilateralabsenceofvasdeferenscbavd
AT yayunwang theroleofslc9a3intaiwanesepatientswithcongenitalbilateralabsenceofvasdeferenscbavd
AT yinghunglin theroleofslc9a3intaiwanesepatientswithcongenitalbilateralabsenceofvasdeferenscbavd
AT yinowu theroleofslc9a3intaiwanesepatientswithcongenitalbilateralabsenceofvasdeferenscbavd
AT hansunchiang roleofslc9a3intaiwanesepatientswithcongenitalbilateralabsenceofvasdeferenscbavd
AT yayunwang roleofslc9a3intaiwanesepatientswithcongenitalbilateralabsenceofvasdeferenscbavd
AT yinghunglin roleofslc9a3intaiwanesepatientswithcongenitalbilateralabsenceofvasdeferenscbavd
AT yinowu roleofslc9a3intaiwanesepatientswithcongenitalbilateralabsenceofvasdeferenscbavd
_version_ 1724861389603864576